decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Answer_Book / Ophthalmology_Services / Coverage_expanded_for_use_of_Visudyne_to_treat_eye_lesions
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare coverage change affecting ophthalmology billing for ocular photodynamic therapy in the treatment of age-related macular degeneration. It is intended for coders and eye care practices that need to understand the scope of the expanded coverage, the general conditions addressed, and the related Medicare noncoverage references.
Why This Topic Matters
Coverage changes can affect whether ophthalmology services and associated drug reporting are payable under Medicare. Understanding the update helps practices recognize when the article’s guidance may apply to AMD-related photodynamic therapy claims.
What You Will Learn
- The general scope of the Medicare coverage expansion for ophthalmic photodynamic therapy
- Which broad AMD-related conditions are discussed in the update
- Which Medicare noncoverage references are mentioned in connection with the topic
- How the article frames billing for the procedure and associated drug reporting
Who Should Read This
- Ophthalmology coders
- Medical billing staff
- Retina and eye care practices
- Medicare compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com